Menu
   
      HOME
 
  Investor Relations
 


 
 


We use the truth hidden in a single drop of blood to improve the quality of life and health across the globe. Our actions uncover the past and reveal the future. We help to understand the known and discover the unknown.

Cormay takes pride in its innovativeness, competitiveness and responsibility.

We protect LIFE,
because it IS A TREASURE

   

 

 

Medica 2017
13-16.11.2017 Dusseldorf

We would like to thank our Business Partners and all attendees for successful time on exhibition.

   
Clinical Chemistry on CAP s Producers Master List

Cormay reagents and chemistry analyzers Accent-200 and Accent-220S are listed on College Of American Pathologist (CAP) Producers Master List.

read more>
   
AACC 2017

The 69th AACC Clinical Lab Expo featured 789 exhibitors. This year Cormay presented clinical chemistry reagents line and analyzers along with SWISS haematology.

   

Paraclin® S NEW

New parasitology system in the offer. Smart way for detection of intestinal parasites

read more>

   

MICROALBUMIN II GENERATION

New quality in determination of Microalbumin due to second generation of reagent.

read more>

   

CMEF 2017

We would like to thank our Business Partners and all attendees for successful time on exhibition in Shanghai.
Cormay presented clinical chemistry reagents line along with products dedicated to haematology.
 

   
 

NEW reagent in offer

New quality in determination of TIBC

read more>

   

ACCENT 220S


NEW analyzer dedicated to clinical chemistry.
Perfect solution for small laboratories.

read more>

   

KG 500  - coagulation analyzer

Fully automated with hight throughput routine assays and 7 measuremet channels. 

  read more>

   
  Archive  
   

 





 

PZ CORMAY Spół‚ka Akcyjna wpisana w S±…dzie Rejonowym dla m.st. Warszawy w Warszawie, XIV Wydział‚ Gospodarczy Krajowego Rejestru S±dowego pod nr KRS:0000270105,
NIP: 1181872269, REGON: 140777556. Wysoko¶ć‡ kapitał‚u zakł‚adowego Spół‚ki: 63 723 954, 00 PLN, wysoko¶ć‡ kapitału wpł‚aconego Spół‚ki: 63 723 954, 00 PLN.